Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 22 | 2022 | 1241 | 2.250 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2021 | 875 | 2.000 |
Why?
|
| Cognitive Dysfunction | 13 | 2022 | 806 | 1.670 |
Why?
|
| Gait | 6 | 2021 | 384 | 1.250 |
Why?
|
| Hippocampus | 6 | 2020 | 200 | 1.200 |
Why?
|
| Cognition | 10 | 2022 | 1026 | 1.080 |
Why?
|
| Alzheimer Disease | 15 | 2022 | 1414 | 1.030 |
Why?
|
| Exercise | 6 | 2021 | 404 | 1.020 |
Why?
|
| Aged, 80 and over | 28 | 2022 | 3865 | 0.960 |
Why?
|
| Aging | 8 | 2021 | 1180 | 0.950 |
Why?
|
| Postural Balance | 3 | 2021 | 112 | 0.810 |
Why?
|
| Independent Living | 5 | 2021 | 240 | 0.800 |
Why?
|
| Neuropathology | 3 | 2021 | 63 | 0.780 |
Why?
|
| Postmortem Changes | 2 | 2016 | 22 | 0.780 |
Why?
|
| Male | 35 | 2022 | 12659 | 0.690 |
Why?
|
| Female | 35 | 2022 | 13142 | 0.680 |
Why?
|
| Wearable Electronic Devices | 5 | 2021 | 41 | 0.660 |
Why?
|
| White Matter | 5 | 2018 | 113 | 0.650 |
Why?
|
| Humans | 47 | 2022 | 23187 | 0.630 |
Why?
|
| Aged | 25 | 2022 | 7660 | 0.590 |
Why?
|
| Autopsy | 9 | 2021 | 260 | 0.570 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2021 | 49 | 0.560 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2018 | 41 | 0.540 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2018 | 96 | 0.510 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 565 | 0.500 |
Why?
|
| Motor Activity | 1 | 2018 | 274 | 0.470 |
Why?
|
| Knee Joint | 1 | 2019 | 572 | 0.440 |
Why?
|
| Thalamus | 3 | 2021 | 15 | 0.430 |
Why?
|
| Atrophy | 3 | 2021 | 68 | 0.430 |
Why?
|
| Parkinsonian Disorders | 3 | 2020 | 170 | 0.390 |
Why?
|
| Accelerometry | 4 | 2021 | 83 | 0.360 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 59 | 0.350 |
Why?
|
| Walking | 4 | 2022 | 235 | 0.350 |
Why?
|
| Neuroimaging | 3 | 2021 | 105 | 0.340 |
Why?
|
| Longitudinal Studies | 7 | 2021 | 1106 | 0.320 |
Why?
|
| Walking Speed | 2 | 2021 | 35 | 0.320 |
Why?
|
| Geriatric Assessment | 3 | 2021 | 171 | 0.320 |
Why?
|
| Gray Matter | 3 | 2021 | 43 | 0.310 |
Why?
|
| Formaldehyde | 1 | 2009 | 7 | 0.300 |
Why?
|
| RNA, Messenger | 2 | 2022 | 283 | 0.300 |
Why?
|
| Cohort Studies | 8 | 2020 | 1467 | 0.290 |
Why?
|
| Temporal Lobe | 2 | 2020 | 58 | 0.280 |
Why?
|
| Parkinson Disease | 4 | 2021 | 595 | 0.280 |
Why?
|
| Brain Mapping | 3 | 2017 | 124 | 0.280 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 152 | 0.270 |
Why?
|
| Dementia | 2 | 2022 | 416 | 0.260 |
Why?
|
| Organ Size | 3 | 2015 | 87 | 0.220 |
Why?
|
| Nerve Net | 2 | 2021 | 34 | 0.200 |
Why?
|
| Neuropsychological Tests | 3 | 2022 | 917 | 0.200 |
Why?
|
| Sclerosis | 3 | 2019 | 54 | 0.200 |
Why?
|
| Transcriptome | 2 | 2022 | 54 | 0.190 |
Why?
|
| DNA Methylation | 3 | 2019 | 129 | 0.190 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 88 | 0.190 |
Why?
|
| Tremor | 2 | 2021 | 98 | 0.180 |
Why?
|
| Proteome | 1 | 2022 | 23 | 0.180 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2021 | 7 | 0.180 |
Why?
|
| Proteomics | 1 | 2022 | 61 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 1 | 2022 | 104 | 0.170 |
Why?
|
| Cognition Disorders | 3 | 2017 | 726 | 0.170 |
Why?
|
| Motor Skills | 1 | 2021 | 38 | 0.170 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2021 | 7 | 0.170 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2019 | 87 | 0.170 |
Why?
|
| Neuropeptides | 2 | 2019 | 22 | 0.170 |
Why?
|
| Frailty | 1 | 2021 | 22 | 0.170 |
Why?
|
| Hand Strength | 1 | 2021 | 49 | 0.170 |
Why?
|
| Sarcopenia | 1 | 2021 | 25 | 0.160 |
Why?
|
| Gene Expression | 2 | 2019 | 180 | 0.160 |
Why?
|
| Cognitive Aging | 1 | 2021 | 64 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 98 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 132 | 0.160 |
Why?
|
| Brain Ischemia | 1 | 2020 | 61 | 0.150 |
Why?
|
| Disabled Persons | 1 | 2021 | 89 | 0.150 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 5 | 0.150 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 104 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 6 | 0.150 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 14 | 0.150 |
Why?
|
| Memory | 3 | 2017 | 225 | 0.150 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 9 | 0.150 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 120 | 0.150 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 21 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 58 | 0.150 |
Why?
|
| Femoracetabular Impingement | 1 | 2020 | 84 | 0.150 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2018 | 10 | 0.150 |
Why?
|
| Electric Stimulation Therapy | 1 | 2018 | 39 | 0.140 |
Why?
|
| Muscle Strength | 1 | 2019 | 99 | 0.140 |
Why?
|
| Bone Resorption | 1 | 2019 | 75 | 0.140 |
Why?
|
| Nerve Fibers | 1 | 2018 | 10 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2019 | 225 | 0.140 |
Why?
|
| Femur | 1 | 2020 | 298 | 0.130 |
Why?
|
| Brain Infarction | 1 | 2017 | 63 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 20 | 0.130 |
Why?
|
| Linear Models | 2 | 2016 | 202 | 0.130 |
Why?
|
| Circle of Willis | 1 | 2017 | 4 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 30 | 0.130 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 21 | 0.130 |
Why?
|
| Neurons | 1 | 2019 | 273 | 0.130 |
Why?
|
| Epithalamus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Afferent Pathways | 1 | 2016 | 4 | 0.130 |
Why?
|
| Plasmacytoma | 1 | 2016 | 8 | 0.130 |
Why?
|
| Sphenoid Sinus | 1 | 2016 | 14 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 73 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 117 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2017 | 140 | 0.120 |
Why?
|
| Algorithms | 2 | 2019 | 305 | 0.120 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 59 | 0.120 |
Why?
|
| Young Adult | 5 | 2021 | 1657 | 0.120 |
Why?
|
| Neocortex | 1 | 2016 | 23 | 0.120 |
Why?
|
| Adult | 8 | 2021 | 6959 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 35 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 279 | 0.110 |
Why?
|
| Joint Instability | 1 | 2019 | 312 | 0.110 |
Why?
|
| Locomotion | 1 | 2014 | 21 | 0.100 |
Why?
|
| Shoulder Joint | 1 | 2019 | 513 | 0.100 |
Why?
|
| Middle Aged | 6 | 2021 | 7981 | 0.100 |
Why?
|
| Memory, Episodic | 1 | 2011 | 81 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2010 | 32 | 0.080 |
Why?
|
| Mortality | 2 | 2021 | 76 | 0.080 |
Why?
|
| Risk Factors | 3 | 2021 | 2020 | 0.080 |
Why?
|
| Fixatives | 1 | 2009 | 5 | 0.070 |
Why?
|
| Sex Factors | 2 | 2021 | 399 | 0.070 |
Why?
|
| Chicago | 2 | 2021 | 847 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 151 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 231 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 139 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 578 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 598 | 0.050 |
Why?
|
| Depression | 2 | 2017 | 383 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2022 | 58 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 14 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 24 | 0.050 |
Why?
|
| Executive Function | 1 | 2022 | 94 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2021 | 20 | 0.040 |
Why?
|
| Frail Elderly | 1 | 2021 | 37 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 202 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2020 | 78 | 0.040 |
Why?
|
| Movement | 1 | 2020 | 106 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 10 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2019 | 2 | 0.040 |
Why?
|
| Nestin | 1 | 2019 | 2 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2019 | 9 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2019 | 7 | 0.040 |
Why?
|
| SNARE Proteins | 1 | 2019 | 9 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 15 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2018 | 11 | 0.040 |
Why?
|
| Software | 1 | 2019 | 50 | 0.040 |
Why?
|
| Life Style | 1 | 2020 | 167 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 48 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 778 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2019 | 102 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 462 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 547 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 369 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 651 | 0.030 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 8 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 12 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 25 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 633 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 804 | 0.030 |
Why?
|
| Shoulder Injuries | 1 | 2019 | 113 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 35 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 216 | 0.030 |
Why?
|
| Netrin Receptors | 1 | 2017 | 4 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 26 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 28 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 1430 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2017 | 54 | 0.030 |
Why?
|
| Habenula | 1 | 2016 | 2 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 730 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 60 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 172 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 160 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 176 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 36 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 122 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 265 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1512 | 0.030 |
Why?
|
| United States | 1 | 2021 | 1803 | 0.030 |
Why?
|
| Actigraphy | 1 | 2016 | 81 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 107 | 0.030 |
Why?
|
| Muscle Rigidity | 1 | 2014 | 13 | 0.030 |
Why?
|
| Hypokinesia | 1 | 2014 | 16 | 0.030 |
Why?
|
| Sleep | 1 | 2016 | 270 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 152 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2013 | 42 | 0.020 |
Why?
|
| Stroke | 1 | 2016 | 243 | 0.020 |
Why?
|
| Cadaver | 1 | 2013 | 284 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 1884 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 445 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 2993 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 521 | 0.020 |
Why?
|